Podcasts about thromboembolism

Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

Commentary by Yugo Yamashita

This podcast features an interview with Laurie Sardo and Julia Bayadinova, experts on Cancer-associated Thrombosis, from Hamilton Ontario, authors of a series of publications in the Canadian Oncology Nursing Journal on Cancer-associated Thrombosis, called Spot the Clot.Laurie Sardo is a Nurse Practitioner in the Thrombosis Service, Department of Hematology at St. Joseph's Healthcare in Hamilton. She graduated with her NP from McMaster University in 2014, and her Doctorate in Nursing Practice from D'Youville University in 2022. Laurie's thesis work focused on patient VTE education in the high-risk cancer population.Her professional interests include patient and staff education and remains active on a number of educational interest groups including the Thrombosis Canada Patient & Family Education committee, the ISTH Nursing committee and the US-based Anticoagulation Forum.ANDJulia Bayadinova, is a nurse practitioner specializing in Thromboembolism, serving both inpatients and outpatients at St. Joseph's Healthcare Hamilton. In 2014, Julia graduated from Ryerson University with a combined Master of Nursing and Primary Care Nurse Practitioner Program, and has since found her passion in Thromboembolism. Her research interest lies in patient education. Julia is currently in pursuit of a Doctorate of Nursing Practice degree at Post University and is completing a thesis on the importance of patient education.In this episode, the two guests review some of the key take-aways from the series of articles. The articles can be accessed here:CAT Series in Canadian Oncology Nursing Journal:The significance of VTE in cancer: Introduction of the ‘Spot the CLOT' serieshttps://www.canadianoncologynursingjournal.com/index.php/conj/article/view/1234Spot the CLOT': What cancer patients want to know https://www.canadianoncologynursingjournal.com/index.php/conj/article/view/1262Spot the CLOT': Awareness of cancer-associated thrombosis in healthcare providershttps://www.canadianoncologynursingjournal.com/index.php/conj/article/view/1277/1067Spot the CLOT: Treatment considerations for CAThttps://www.canadianoncologynursingjournal.com/index.php/conj/article/view/1372Support the showhttps://thrombosiscanada.caTake a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada

The Oncology Journal Club - Delivering Oncology News DifferentlyThe Oncology Podcast, brought to you by The Oncology Network, is proud to present Episode 1 in the second series of The Oncology Journal Club.Join Professor Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson in this trans-Tasman review of 2023 practice-changing papers.For papers, bios and other links visit the Show Notes on our website.For the latest oncology news visit www.oncologynews.com.au.We invite healthcare professionals to join The Oncology Network for free - you'll also receive our free weekly publication The Oncology Newsletter.The Oncology Podcast - An Australian Oncology Perspective

The Oncology Journal Club - Delivering Oncology News DifferentlyThe Oncology Podcast, brought to you by The Oncology Network, is proud to present Part 2 of our 2023 Review Episode of The Oncology Journal Club.Join Professor Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson in this trans-Tasman review of 2023 practice-changing papers.For papers, bios and other links, visit our website's Show Notes.For the latest oncology news visit www.oncologynews.com.au.We invite healthcare professionals to join The Oncology Network for free - you'll also receive our free weekly publication The Oncology Newsletter.The Oncology Podcast - An Australian Oncology Perspective

This is a recording from the live webinar was conducted live December 13, 2023. This is an annual event that is held every year in mid-December celebrating the top hair research studies.    DERMATOPATHOLOGY   Douglas A et al. Scalp Biopsy Influences Diagnostic Accuracy and Treatment in Black Women with Alopecia: A Retrospective Study. J Am Acad Dermatol. 2023 Jan 31;S0190-9622(23)00157-3.   ANDROGENETIC ALOPECIA Gupta AK et al.The relative efficacy of monotherapy with 5-alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta-analysis study. J Cosmet Dermatol. 2023 Jun 29 Jimenez-Cauhe J et al. Safety of Low-Dose Oral Minoxidil in Patients With Hypertension and Arrhythmia: A Multicenter Study of 264 Patients. Actas Dermosifiliogr. 2023 Aug 29:S0001-7310(23)00679-8.   ALOPECIA AREATA   Gandhi et al.The Association of Alopecia Areata-Related Emotional Symptoms with Work Productivity and Daily Activity Among Patients with Alopecia Areata. Dermatol Ther (Heidelb). 2023 Jan;13(1):285-298.   Li SJ et al. Experiencing Workplace Bullying in Patients with Alopecia Areata: A Cross-Sectional Survey Study. Skin Appendage Disord. 2023 Aug;9(4):258-261   Kazmi A et al. Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response. J Am Acad Dermatol. 2023 Apr 4;S0190-9622(23)00532-7.   King B et al. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial. Lancet. 2023 May 6;401(10387):1518-1529.   George P et al. Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database., Dermatol Ther (Heidelb). 2023 Aug; 13(8): 1733–1746.   Wang C-W et al. Clinical characteristics and immune profiles of patients with immune-mediated alopecia associated with COVID-19 vaccinations. Clin Immunol. 2023 Oct:255:109737.   Chen J et al. The Incidence of Alopecia Areata in a COVID-19- Vaccinated Population: A Single-Center Review. Cureus 2023   TELOGEN EFFLUVIUM   Michelini S et al. Telogen Effluvium in SARS-CoV-2 Infection: histological aspects. J Eur Acad Dermatol Venereol. 2023 Mar 8.   TINEA CAPITIS Gold, JA et al. Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States. J Am Acad Dermatol. 2023 Feb 15;S0190-9622(23)00189-5.   COSMETIC DERMATOLOGY Landau M et al. Nonscarring alopecia after temporal lifting technique with dermal fillers. JAAD Case Rep. 2023 May 12;37   FOLLICULITIS DECALVANS Matard B et al. Folliculitis decalvans and dystrophic epidermolysis bullosa: a significant association. Br J Dermatol 2022 Dec;187(6):1026-1028. DISCOID LUPUS Fredeau L et al. Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: a registry-based cohort study of 164 patients. J Am Acad Dermatol. 2023 Mar;88(3):551-559.   DISSECTING CELLULITIS Cajas-Garcia MS et al.  Distinct presentations of scalp dissecting cellulitis manifesting with furrows and gyri. J Eur Acad Dermatol Venereol. 2023 Feb 3.   LICHEN PLANOPILARIS Lim SH et al. Prevalence and Incidence of Comorbid Diseases and Mortality Risk Associated with Lichen Planopilaris: A Korean Nationwide Population-Based Study. Clin Exp Dermatol. 2023 Jul 11;llad235 GENERAL SCARRING ALOPECIA Kim SR et al.  Association of Primary Cicatricial Alopecia with Subsequent Cardiovascular Disease. J Invest Dermatol. 2023 Nov 19:S   CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA Joshi TP et al.  Comorbidities in patients with central centrifugal cicatricial alopecia: a case-control study. Int J Dermatol. 2023 Nov 23.   ACNE KELOIDALIS NUCHAE Lobato-Berezo A et al. Acne keloidalis nuchae: An international multicentric review of 79 patients. J Eur Acad Dermatol Venereol. 2023 Nov 1.

Dr. Zach Cost and Dr. Tem Bendapudi join the show to discuss the literature pertaining to tranexamic acid and thromboembolic risk. Dr. Zach Cost is an anesthesia resident at the Massachusetts General Hospital. Dr. Pavan (“Tem”) Bendapudi holds a joint faculty appointment in the Division of Hematology and Blood Transfusion Service and is assistant professor of medicine at Harvard Medical School. This podcast was recorded as part of the Depth of Anesthesia podcast elective. Thanks for listening! If you enjoy our content, leave a 5-star review on Apple Podcasts and share our content with your colleagues. — Follow us on Instagram @DepthofAnesthesia and on Twitter (X) @DepthAnesthesia for podcast and literature updates. Email us at depthofanesthesia@gmail.com with episode ideas or if you'd like to join our team. Music by Stephen Campbell, MD. — References CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. PMID: 20554319. Henry DA, Carless PA, Moxey AJ, et al. Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. 2011;(1). doi:10.1002/14651858.CD001886.pub3 Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054. doi:10.1136/bmj.e3054 Myles PS, Smith JA, Forbes A, et al. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. New England Journal of Medicine. 2017;376(2):136-148. doi:10.1056/NEJMoa1606424 Devereaux PJ, Marcucci M, Painter TW, et al. Tranexamic Acid in Patients Undergoing Noncardiac Surgery. New England Journal of Medicine. 2022;386(21):1986-1997. doi:10.1056/NEJMoa2201171 POISE 3 PeriOperative ISchemic Evaluation-3 (POISE-3) study Shakur H, Roberts I, Fawole B, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum hemorrhage (WOMAN): an international, randomized, double-blind, placebo-controlled trial. The Lancet. 2017;389(10084):2105-2116. doi:10.1016/S0140-6736(17)30638-4 Roberts I, Shakur-Still H, Afolabi A, et al. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. The Lancet. 2020;395(10241):1927-1936. doi:10.1016/S0140-6736(20)30848-5 Taeuber I, Weibel S, Herrmann E, et al. Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Surgery. 2021;156(6):e210884. doi:10.1001/jamasurg.2021.0884

Commentary by Dr. Valentin Fuster

Podcast summary of articles from the June 2023 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include pediatric cardiopulmonary resuscitation, Step 1 scores, timing of thrombolytics for stroke, gastroenterology, HEENT emergencies, and thromboembolisms.  Guest speaker is Dr. Matthew Carvey.

STUDIES REFERENCE IN THE EPISODE   SWITCHING FROM TOFACITINIB TO BARICITINIB   Kazmi A et al (starts at 12:33). Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response. J Am Acad Dermatol. 2023 Apr 4;S0190-9622(23)00532-7.     RITLECITINIB IN ADOLESCENTS   Hordinsky M et al (starts at 21:31). Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial. Pediatr Dermatol. 2023 Jul 17.     RISK OF INFECTIONS, CANCER, HEART DISEASE AND BLOOD CLOTS IN AT/AU   George P et al (starts at 36:08). Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database., Dermatol Ther (Heidelb). 2023 Aug; 13(8): 1733–1746.     Schneeweiss MC et al (starts at 37:36). Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases. JAMA Dermatol. 2021 Jul 1;157(7):805-816.     MARKERS OF VENOUS THROMBOEMBOLISM IN ALOPECIA AREATA   Sudnik W et al (starts at 57:40) . The role of selectins in alopecia areata. Postepy Dermatol Alergol. 2015 Feb;32(1):27-32.   Shakoei S et al (starts at 58:23). Coagulation status in patients with alopecia areata: a cross-sectional study. Ital J Dermatol Venerol. 2021 Oct;156(5):588-592.   Waśkiel-Burnat A et al (starts at 59:30). Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about? Dermatol Ther (Heidelb). 2023 Aug;13(8):1847-1855.     HABIT REPLACEMENT THERAPY FOR TRICHOTILLOMANIA   Moritz S et al (starts at 1:04:34). Self-Help Habit Replacement in Individuals With Body-Focused Repetitive Behaviors: A Proof-of-Concept Randomized Clinical Trial.  JAMA Dermatol. 2023 Jul 19;e232167.   LINK TO VIDEO on HRT DEMONSTRATION https://clinical-neuropsychology.de/habit-replacement-en/#sthash.J6iQiYRi.dpuf    

Welcome to Episode 26 of “The 2 View,” the podcast for EM and urgent care nurse practitioners and physician assistants! Show Notes for Episode 26 of “The 2 View” – Save time charting & code accurately, dementia, PE in pregnancy, and the PCN shortage. PCN Shortage Ault, A. FDA Drug Shortages. Current and Resolved Drug Shortages and Discontinuations Reported to FDA. FDA issues new rule on drug shortages. Community Oncology, 9(1), 34. U.S. Food & Drug. Published April 26, 2023. Accessed May 9, 2023. https://doi.org/10.1016/j.cmonc.2011.12.003 Bendix, A. Shortage of penicillin limits access to the go-to drug for syphilis. NBC News. Published April 27, 2023. Accessed May 9, 2023. https://www.nbcnews.com/health/health-news/shortage-penicillin-limits-access-go-drug-syphilis-rcna81777 Global shortages of penicillin. Shortages of benzathine penicillin. Global Sexually Transmitted Infections Programme. World Health Organization. Who.int. Accessed May 9, 2023. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/stis/treatment/shortages-of-penicillin Dementia Alzheimer's Disease Fact Sheet. Alzheimer's Disease and Related Dementias: Basics of Alzheimer's Disease and Dementia. National Institute on Aging. Accessed May 9, 2023. https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet Home. Alzheimer's Disease and Dementia. Alzheimer's Association. Accessed May 9, 2023. https://www.alz.org/ Silbert, L, Erten-Lyons, D. Memory Loss, Confusion in a 51-Year-Old Fired From Her Job. Medscape. Published March 2, 2023. Accessed May 9, 2023. https://reference.medscape.com/viewarticle/850363 PE in Pregnancy Negaard M. YEARS Algorithm for pulmonary embolism (PE). MDCalc. Accessed May 9, 2023. https://www.mdcalc.com/calc/4067/years-algorithm-for-pulmonary-embolism-pe Stals MAM, Moumneh T, Ainle FN, et al. Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data. J Thromb Haemost. 2023;21(3):606-615. NIH: National Library of Medicine: National Center for Biotechnology Information. PubMed. Published December 22, 2022. Accessed May 9, 2023. https://pubmed.ncbi.nlm.nih.gov/36696189/ Thromboembolism in Pregnancy. ACOG: The American College of Obstetricians and Gynecologists. Acog.org. Practice Bulletin, Number 196. Published July 2018. Accessed May 9, 2023. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2018/07/thromboembolism-in-pregnancy Charting & Coding 2023 Emergency Department Evaluation and Management Guidelines. ACEP: American College of Emergency Physicians. Acep.org. Last Updated: October 2022. Accessed May 9, 2023. https://www.acep.org/administration/reimbursement/reimbursement-faqs/2023-ed-em-guidelines-faqs American Medical Association. 2023 Emergency Medicine Coding Guide. MDCalc. Accessed May 9, 2023. https://www.mdcalc.com/calc/10454/2023-emergency-medicine-coding-guide CPT Evaluation and Management (E/M) Code and Guideline Changes. AMA: American Medical Association. Ama-assn.org. Accessed May 9, 2023. https://www.ama-assn.org/system/files/2023-e-m-descriptors-guidelines.pdf ICD-10-CM Coding for Social Determinants of Health. AHA: American Hospital Association – Advancing Health in America. Aha.org. Published January 2022. Accessed May 9, 2023. https://www.aha.org/system/files/2018-04/value-initiative-icd-10-code-social-determinants-of-health.pdf Level of MDM (based on 2 of 3 elements of MDM) number and complexity of problems addressed. ACEP: American College of Emergency Physicians – Advancing Emergency Care. ERCODER. Acep.org. Accessed May 9, 2023. https://www.acep.org/siteassets/sites/acep/media/reimbursement/acep---2023-ed-mdm-grid.pdf Recurring Sources Center for Medical Education. Ccme.org. http://ccme.org The Proceduralist. Theproceduralist.org. http://www.theproceduralist.org The Procedural Pause. Emergency Medicine News. Lww.com. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx The Skeptics Guide to Emergency Medicine. Thesgem.com. http://www.thesgem.com Trivia Question: Send answers to 2viewcast@gmail.com Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to. Be sure to listen in and see what we have to share!

Commentary by Drs. Isabelle Mahé, Florian Scotté and Ismail Elalamy

Commentary by Dr. Teresa Lopez Fernandez

This week we delve into the world of electrophysiology when we review a recent multicenter work on the rare topic of atrial standstill. What is atrial standstill and how does it differ from SA node dysfunction? What risks are associated with this condition and how can they be mitigated? Are there factors in an atrial standstill patient that might prompt implantation of a primary prevention ICD? We speak with the first author of this week's work, Dr. Taylor Howard who is Assistant Professor of Pediatrics at Baylor College of Medicine and an attending physician in pediatric electrophysiology at Texas Children's Hospital about his most recent work. doi: 10.1016/j.jacep.2022.08.022. Epub 2022 Oct 26.

Commentary by Dr. Valentin Fuster

    Vidcast:  https://youtu.be/zk7Z0hbeK7I   Strokes don't occur often in young adults, but having Type A blood increases your risk of having a debilitating early onset stroke 16% while having type O blood reduces that risk by 12%.  Epidemiologists at the University of Maryland's School of Medicine draw these conclusions from their meta-analysis of 16,927 stroke victims who participated in 48 different multi-national studies.  The control group consisted of nearly 600,000 persons without a stroke history.   These blood group associations were stronger in younger patients. The analysis also demonstrated an association of the same blood groups with early venous thromboembolism, a key driver of early stroke.   https://www.jbc.org/article/S0021-9258(21)00552-4/fulltext#%20   #abogrups #stroke #thromboembolism  

"The most number of acronyms in a podcast ever" The New York Tymes This episode is proudly supported by Zylkene from Vetquinol- a safe way to help your dog or cat that may be stressed or have a mild anxiety - safe in the young, the old, the big and the small, in the Canine, or the Feline. This Episode is Also proudly brought to you by Delicate Care, an Australian Made, and Australian Owned diet, focusing on diets for various life stages and disease states. Check out the Website for more details. Did you know that for as little as $2 per month, you can become a Patreon supporter of the podcast. That's only $0.50 per episode! But if you want you can sign up to one of the other options, and get some sweet TVTP merch! With Q&A sessions , outtakes, and bonus episodes available for you to listen to now, sign up and get yourself amongst the fun! If you have any questions that you'd like to ask Lewis and Robbie send us an email at twovetstalkpets@gmail.com, or you can contact us or find us on Instagram, Twitter, or Facebook. --- Send in a voice message: https://anchor.fm/twovetstalkpets/message

In this episode have a conversation with Dr Matthew Nicholson and Dr Noel Chan on their recent publication from Blood Review entitled No apparent association between mRNA COVID-19 vaccination and venous thromboembolism (https://www.sciencedirect.com/science/article/pii/S0268960X22000443) which was co-authored by Dr Hadi Goubran and Dr Deborah Siegal.Dr. Matthew Nicholson is a Clinical Hematologist at the Saskatoon Cancer Centre and an Assistant Professor in the College of Medicine at the University of Saskatchewan. He obtained his MD and Internal Medicine residency at the University of Saskatchewan in Saskatoon. Dr. Nicholson completed his Hematology fellowship training at the University of British Columbia in Vancouver and completed a clinical fellowship in thrombosis medicine through McMaster University, and is board certified in Internal Medicine and Hematology. Dr. Nicholson has acted as an advocate for improved training conditions for medical students and residents during his time with provincial health organizations and the resident doctors of Canada board. He co-authored the resident Doctors of Canada "Data Collection and Learner Privacy Principles" which have been adopted to help govern learner privacy rights in medical colleges and medical licensing bodies across Canada.His research interests include Venous Thromboembolism (VTE), thromboprophylaxis, and hemophagocytic lymphohistiocytosis (HLH).ANDDr Noel Chan, is an Assistant Professor in the Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton ON, Canada, specializing in anticoagulant therapy and thrombosis medicine. His research seeks to improve our understanding of the triggers for thrombosis (including the role of inflammation) and the determinants of variable response to antithrombotic therapies to inform on novel strategies with the potential to further reduce the burden of thrombosis.Follow us on Twitter:Dr Matthew Nicholson: @Matt_BloodMDThrombosis Canada: @ThrombosisCanReference:Nicholson, M., Goubran, H., Chan, N., & Siegal, D. (2022). No apparent association between mRNA COVID-19 vaccination and venous thromboembolism. Blood Reviews, 100970.Support the showhttps://thrombosiscanada.caTake a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada

Podcast summary of articles from the June 2022 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include hand and finger lacerations, thromboembolism in COVID, ultrasound guided subclavian lines, difficult airway, nasal TXA, and pediatric opioid prescriptions.  Guest speaker is Dr. Tyler Hughes.  

In this episode of ER VET, Dr. Justine Lee, DACVECC, DABT reviews a rare – but deadly – cause of difficulty breathing in dogs and cats: pulmonary embolism. In veterinary medicine, pulmonary thromboembolism (PTE) can be caused by numerous causes – with some being potentially preventable! SHOW NOTES: Pulmonary Thromboembolism In Dogs And Cats

ACC Recap: John Mandrola, MD, provides part 1 of an ACC recap in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I – HTN in Pregnancy - Hypertension Control During Pregnancy Validated in Large Trial https://www.medscape.com/viewarticle/971486 - Treatment for Mild Chronic Hypertension during Pregnancy https://www.nejm.org/doi/full/10.1056/NEJMoa2201295 II – Prevention of Bleeding in Non-Cardiac Surgery - POISE-3 Backs Wider Use of Tranexamic Acid in Noncardiac Surgery https://www.medscape.com/viewarticle/971483 - Tranexamic Acid in Patients Undergoing Noncardiac Surgery https://www.nejm.org/doi/full/10.1056/NEJMoa2201171 III – HCM - VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in OHCM https://www.medscape.com/viewarticle/971484 IV – Left Atrial Appendage Occlusion - Small Leaks After LAAO Linked to Thromboembolism, Bleeding https://www.medscape.com/viewarticle/971709 V – Low Sodium Diet for HF - Low-Sodium Diet Did Not Cut Clinical Events in Heart Failure Trial https://www.medscape.com/viewarticle/971482 - Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial https://doi.org/10.1016/S0140-6736(22)00369-5 VI – Flu Vaccine and Heart Failure - Flu Vaccines Cut Seasonal Death in Patients With Heart Failure https://www.medscape.com/viewarticle/971619 VII – New Anticoagulant? - Less Bleeding With Factor XI Inhibitor Anticoagulant? PACIFIC-AF https://www.medscape.com/viewarticle/971702 Features: - Sodium Restriction in Heart Failure: Another Dogma Felled by Randomization https://www.medscape.com/viewarticle/971697 - Percutaneous Left Atrial Appendage Occlusion: ACC Data Challenge Promise vs Reality https://www.medscape.com/viewarticle/971512 - Mavacamten in Hypertrophic Cardiomyopathy: Reasons for Both Optimism and Caution https://www.medscape.com/viewarticle/971485 You may also like: Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact: news@medscape.net

Welcome back to the VTE Dublin Podcast where you'll find all the recent talks from the VTE Dublin Conference. Be sure to subscribe to the VTE Dublin Podcast Video: Audio:

In this episode, we review the high-yield topic of Thromboembolism (PE & DVT) Prophylaxis from the Basic Science section. Follow Orthobullets on Social Media: Facebook: www.facebook.com/orthobullets Instagram: www.instagram.com/orthobulletsofficial Twitter: www.twitter.com/orthobullets LinkedIn: www.linkedin.com/company/27125689 YouTube: www.youtube.com/channel/UCMZSlD9OhkFG2t25oM14FvQ --- Send in a voice message: https://anchor.fm/orthobullets/message

In this episode, we review the high-yield topic of Pulmonary Thromboembolism from the Respiratory section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets --- Send in a voice message: https://anchor.fm/medbulletsstep1/message

From our Emergency Medicine and Acute Care course, listen to a faculty discussion pertaining to recent emergency medicine literature.  The topics include: acute pain treatment treatment, opioid prescribing, Syncope topics, Venous Thromboembolism, Subsegmental Pulmonary Embolism, DVT, Anaphylaxis, Cervicitis, Pelvic Inflammatory Disease, STDs, Button Battery Injury, Pulmonary Disease, Imaging, Antiobiotic-Associated Diarrhea, Diabetic Ketoacidosis Learn more at https://courses.ccme.org/course/ema

Here are the links for everything discussed in Episode 64. Times are also below so feel free to skip around and get to the drugs that interest you. (1:23) New pediatric indication for Ultomiris for PNH (5:18) Pradaxa now approved for VTE in pediatric patients (9:34) Rx to OTC switch of Astepro CDC updates on COVID-19 & influenza reporting Connect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Commentary by Dr. Bonnie Ky

Join Yvonne Brandenburg, RVT, VTS SAIM and Jordan Porter RVT, LVT, VTS SAIM as we talk about: Pulmonary thromboembolism, or PTE as we call it. We get down into the lungs when clots go haywire and end up deep in the lungs, but cause some major problems for our patients.    Question of the Week What is something you accomplished this week, or something you are proud of?  Leave a comment at https://imfpp.org/episode83   Resources We Mentioned in the Show   Bonagura, J. D., & Twedt, D. C. (2014). Kirk's Current Veterinary Therapy (15 ed.). pp. 705-710. St. Louis: Elsevier Merrill, L. (2012). Small Animal Internal Medicine for Veterinary Technicians and Nurses. Ames: Wiley - Blackwell. Merck Veterinary Manual: Respiratory System; Pulmonary Thromboembolism https://www.merckvetmanual.com/respiratory-system/respiratory-diseases-of-small-animals/pulmonary-thromboembolism-in-small-animals VIN:  vin.com/apputil/content/defaultadv1.aspx?id=7054600&pid=12886   Carol Reinero, Lance C. Visser, Heidi B. Kellihan, Isabelle Masseau, Elizabeth Rozanski, Cécile Clercx, Kurt Williams, Jonathan Abbott, Michele Borgarelli, Brian A. Scansen. J Vet Intern Med. 2020 Mar; 34(2): 549–573.  Published online 2020 Feb 17. doi: 10.1111/jvim.15725.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629428/ DVM360: Pulmonary Thromboembolism Proceedings:  https://www.dvm360.com/view/pulmonary-thromboembolism-proceedings Thanks so much for tuning in. Join us again next week for another episode!  Want to earn some RACE approved CE credits for listening to the podcast? You can earn between 0.5-1.0  hour of RACE approved CE credit for each podcast episode you listen to.    Join the Internal Medicine For Vet Techs Membership to earn and keep track of your continuing education hours as you get your learn on!   Join now! http://internalmedicineforvettechsmembership.com/   Get Access to the Membership Site for your RACE approved CE certificates Sign up at https://internalmedicineforvettechsmembership.com  Get Access to the Technician Treasure Trove  Sign up at https://imfpp.org/treasuretrove    Thanks for listening!  – Yvonne and Jordan 

Guest host Ted Michaels welcomed Dr. Menaka Pai to the show to talk about the concerns about combining blood thinners with a COVID-19 vaccine. Guest: Dr. Menaka Pai, Head of Service, Benign Hematology, Hamilton Health Sciences, and Associate Professor in Hematology & Thromboembolism at McMaster University, Hamilton, Ontario Check out the newest podcast of the Scott Thompson Show for a look at how to maintain good financial, physical and mental health in 2021! Want to keep up with Ted Michaels on The Health & Wellness Show? Visit the show's homepage and subscribe to the podcast wherever you get your favourite shows! https://globalnews.ca/hamilton/program/health-and-wellness-show See omnystudio.com/listener for privacy information.

In this episode of Critical Matters, we will discuss thrombosis in COVID-19. We will discuss the pathophysiology, diagnosis, and management of arterial and venous thrombosis in COVID-19. Our guest is Dr. Gregory Piazza, a cardiovascular medicine specialist at Brigham and Women’s Hospital in Boston. Dr. Piazza is the Director of the Vascular Medicine Section, in the Division of Cardiovascular Medicine, and Associate Professor of Medicine, at Harvard Medical School. Additional Resources: Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19: https://jamanetwork.com/journals/jama/fullarticle/2773516 Registry of Arterial and Venous Thromboembolic Complications in Patients with COVID-19: https://www.jacc.org/doi/full/10.1016/j.jacc.2020.08.070 ACCP Guidelines for Management Thromboembolism in COVID-19: https://journal.chestnet.org/article/S0012-3692(20)31625-1/fulltext ISTH Guidelines for Management of Thromboembolism in COVID-19: https://onlinelibrary.wiley.com/doi/10.1111/jth.14929 Books Mentioned in this Episode: Dune by Frank Herbert: https://www.amazon.com/Dune-Frank-Herbert

FDA 批准治疗慢性免疫性血小板减少症的新药BMJ 术后血栓预防中，加压袜并不能提供额外的获益Nature子刊 白血病治疗性疫苗的研制阿凡波帕（avatrombopag）阿凡波帕（avatrombopag）血小板生成素受体激动剂。在上周三《消化科星期三 Episode 23》中已经给介绍了阿凡波帕用于治疗慢性肝病合并血小板减少患者的手术前用药，可以改善血小板计数、减少出血和输血。2019年6月，该药的适应症被扩展至慢性免疫性血小板减少。《随机对照研究：阿凡波帕治疗慢性免疫血小板减少症的3期临床研究》British Journal of Haematology，2018年11月 (1)这个安慰剂对照、多中心、随机、双盲的3阶段的研究，目的是评估阿凡波帕20mg qd治疗成人慢性、免疫性血小板减少症的疗效。研究纳入49位患者，入组时血小板计数

FDA 批准治疗慢性免疫性血小板减少症的新药BMJ 术后血栓预防中，加压袜并不能提供额外的获益Nature子刊 白血病治疗性疫苗的研制阿凡波帕（avatrombopag）阿凡波帕（avatrombopag）血小板生成素受体激动剂。在上周三《消化科星期三 Episode 23》中已经给介绍了阿凡波帕用于治疗慢性肝病合并血小板减少患者的手术前用药，可以改善血小板计数、减少出血和输血。2019年6月，该药的适应症被扩展至慢性免疫性血小板减少。《随机对照研究：阿凡波帕治疗慢性免疫血小板减少症的3期临床研究》British Journal of Haematology，2018年11月 (1)这个安慰剂对照、多中心、随机、双盲的3阶段的研究，目的是评估阿凡波帕20mg qd治疗成人慢性、免疫性血小板减少症的疗效。研究纳入49位患者，入组时血小板计数

Dr. Kelly Diehl talks with Drs. Josh Stern and Ronald Li, Morris Animal Foundation-funded researchers at the University of California, Davis, School of Veterinary Medicine. They discuss how arterial thromboembolism in cats is treated, as well as their efforts to improve diagnosis and treatments.

How are school boards adapting for the COVID-19 situation? HWDSB has proposed a plan to reduce class sizes and dip into reserve funds. While the HWDSB will hold media availability later on today, Alex joins us earlier to discuss last night's trustee meeting and the plan. Guest: Alex Johnstone, Trustee & Chair, Hamilton Wentworth District School Board - London's TVDSB is also going to dip into their reserves as well for the new year. Guest: Craig Smith, ETFO Thames Valley Teacher Local President - The US has given emergency approval for blood plasma to be used to help hospitalized COVID-19 patients. Why are they going with plasma? Wasn't there promising word about a vaccine a few weeks ago? Guest: Dr. Anna Banerji (ban-er-ji), O.Ont MD MPH FRCPC DTM&H, Faculty Lead, Indigenous and Refugee Health, Post MD Education, Faculty of Medicine, , University of Toronto - Dr. Don Arnold of McMaster University is Canada's lead on plasma research and whether it's effective for treatment. What has he seen in his research about COVID-19 recovery and plasma? Guest: Dr. Donald Arnold, Associate Professor, Division of Hematology and Thromboembolism, Department of Medicine, McMaster University - With the school year approaching, there are some parents who are opting for their kids to learn from home. But how is virtual learning coming along?  Guest: David Hutchison, PhD, PMP, Professor, Department of Educational Studies, Faculty of EducationCentre for Digital Humanities, Faculty of Humanities, Director, GAME Program, Brock University

Welcome back to the VTE Dublin Podcast where you’ll find all the recent talks from the VTE Dublin Conference. Be sure to subscribe to the VTE Dublin Podcast Home Treatment of Pulmonary Thromboembolism – are we ready for it? Prof Menno Huisman | Professor of Haemostasis and Thrombosis | Leiden University | Netherlands iTunes | […]

Podcast summary of articles from the June 2020 edition of the Journal of Emergency Medicine from the American Academy of Emergency Medicine.  Topics include chest pain, ketamine sedations, stroke scores, venous thromboembolism in cancer patients, akathisia, and board review on pediatric magnet ingestions.  Guest speaker is Dr. Greg Adams.

You don't just put a filter in and forget about it—but that's what used to happen. And when you put a filter in, it's like anything else. We are clinical physicians in IR and vascular surgery, and when we put these filters in your patient, you need to follow them. That means clinical follow-up, and it may mean imaging follow-up. —Matthew S. Johnson, MD, FSIRWarren Krackov, MD, FSIR, speaks with interventional radiologist Matthew S. Johnson, MD, FSIR, about the evolution of IVC filters, the upcoming IVC filter clinical practice guidelines, and the status of the FDA-requested PRESERVE Study. Read the IVC filter clinical practice guidelines.Note: This episode was recorded on June 1, 2020.Contact us with your ideas and questions, or read more about about interventional radiology in IR Quarterly magazine or SIR's Patient Center.(c) Society of Interventional Radiology.Support the show (https://www.sirweb.org/corporate-gateway/advertising/)

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians | Prevention of Venous Thromboembolism: AHA Call for Action May 2020 | Not Medical Advice or Opinion Henke PK, Kahn SR, Pannucci CJ, et al :Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association. Circulation 2020;May 7:[Epub ahead of print].

In the second episode we are chatting a bit more about veterinary life in lockdown. Scott will be talking more about gastroprotectant medications in dogs and cats. Similar to the situation in human medicine, practice of inappropriate prescription of acid suppressants is also commonplace in veterinary medicine. We challenge the dogma and clinical practice of administering gastroprotectants for the routine management of many conditions and discuss some of the negative effects of giving omeprazole. We will also be bringing you the second edition of ‘Desert Island Drugs' where Liz and Scott will be discussing drug choices for the management of aortic thromboembolism in cats. For more information about vtx, please visit our website: www.vtx-cpd.com   For a full webinar on aortic thromboembolism please visit:   https://vtx-cpd.com/webinars/fat-cat-vs-super-cat-whats-new-in-fate/     We want to know #whatareyouthinking? If you have a topic you would like discussed, please drop us an email info@vtx-cpd.com

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians| CARAVAGGIO Trial: Is Apixaban safe and efficacious in Cancer Venous Thromboembolism?-NEJM April 2020 | Not Medical Advice or Opinion Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer N Engl J Med 2020; 382:1599-1607 Anticoagulant Therapy for Venous Thromboembolism in Cancer N Engl J Med 2020; 382:1650-1652 Tukaye DN, Brink H, Baliga R. Venous thromboembolism in cancer patients: risk assessment, prevention and management. Future Cardiol. 2016;12(2):221‐235. doi:10.2217/fca.15.87 Arcopinto M, Cella CA, Wesolowski R, et al. Primary prevention of cancer-related thrombosis: special focus on ambulatory patients. Int J Cardiol. 2014;173(3):583‐584. doi:10.1016/j.ijcard.2014.03.109

In this podcast, Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clincial guidance related to covid-19. Emma Scott covers the latest on routine immunisation. Abigail Davis discusses advice on thromboembolism and advice on mental health care for healthcare workers. And Matt Castleden summarises the current standing on contact tracing. For more, see: BMJ Best Practice's topic on management of coexisting conditions in the context of COVID-19: bestpractice.bmj.com/topics/en-gb/3000190 BMJ Best Practice's topic on covid-19: bestpractice.bmj.com/topics/en-gb/3000168 BMJ Learning module on COVID-19 rapid guideline on critical care (NICE): learning.bmj.com/learning/module-intro/covid-19-nice-guidelines.html?moduleId=10065100 PHE contact tracing letters: gov.uk/government/publications/contact-tracing-letter-to-directors-of-public-health Emergency Responders: tips for taking care of yourself: emergency.cdc.gov/coping/responders.asp NHS England Clinical Guide for the Management of Anticoagulant Services during the coronavirus pandemic: england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/C0077-Specialty-guide_Anticoagulant-services-and-coronavirus-v1-31-March.pdf WHO Guiding principles for immunization activities during the COVID-19 pandemic: apps.who.int/iris/handle/10665/331590 - The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

In this podcast, Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clincial guidance related to covid-19. Emma Scott covers the latest on routine immunisation. Abigail Davis discusses advice on thromboembolism and advice on mental health care for healthcare workers. And Matt Castleden summarises the current standing on contact tracing. For more, see: BMJ Best Practice's topic on management of coexisting conditions in the context of COVID-19: bestpractice.bmj.com/topics/en-gb/3000190 BMJ Best Practice's topic on covid-19: bestpractice.bmj.com/topics/en-gb/3000168 BMJ Learning module on COVID-19 rapid guideline on critical care (NICE): learning.bmj.com/learning/module-intro/covid-19-nice-guidelines.html?moduleId=10065100 PHE contact tracing letters: gov.uk/government/publications/contact-tracing-letter-to-directors-of-public-health Emergency Responders: tips for taking care of yourself: emergency.cdc.gov/coping/responders.asp NHS England Clinical Guide for the Management of Anticoagulant Services during the coronavirus pandemic: england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/C0077-Specialty-guide_Anticoagulant-services-and-coronavirus-v1-31-March.pdf WHO Guiding principles for immunization activities during the COVID-19 pandemic: apps.who.int/iris/handle/10665/331590 - The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner's judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Carbon Monoxide and the Association with Thromboembolism.mp3 by Oregon 1-800-222-1222

Preventing Strokes in Atrial Fibrillation -2 2019 ACC/AHA/HRS Update Dr RR Baliga's MUST KNOW FACTs PodCasts for Physicians from Journal of Am Coll Cardiology 2019;74:104-132

Preventing Strokes in Atrial Fibrillation -1 2019 ACC/AHA/HRS Update Dr RR Baliga's MUST KNOW FACTs PodCasts for Physicians from Journal of Am Coll Cardiology 2019;74:104-132

Practice Bulletin #196 - Published July 2018 We'll cover: - why are pregnant women at higher risk of VTE? - risk factors for VTE in pregnancy - who and how to treat and prevent VTE in pregnancy - what to do for women on thromboprophylaxis who present for delivery - thromboprophylaxis postpartum -...and more! Shout-outs: - The Farm, the greatest place on earth to give birth for many people (my words) - Sara Rosser, midwife at The Farm on Instagram - Ilana Stanger-Ross and her pregnancy book "A is for Advice" SHOW NOTES This episode pairs nicely with the 2017 Tempranillo Viura by Casado Morales Winery. Main theme music by my main amigo, Evan Handyside

In this episode, we review the high-yield topic of Thromboembolism (PE & DVT) from the Basic Science section. --- Send in a voice message: https://anchor.fm/orthobullets/message

 Alok Khorana, MD, of the Cleveland Clinic joins Blood & Cancer host David H. Henry, MD, of Pennsylvania Hospital, Philadelphia, to break down the latest recommendations from the American Society of Clinical Oncology on venous thromboembolism (VTE) prophylaxis in cancer patients. Plus, in Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, shares her answer to a frequent question from cancer patients: What should I eat? This Week in Oncology What is the role of thromboprophylaxis in patients with cancer in the outpatient setting?  Key change in ASCO recommendations: Thromboprophylaxis with apixaban, rivaroxaban, or low-molecular-weight heparin (LMWH) may be offered to select high-risk outpatients with cancer. Prophylactic anticoagulation should not be given to every patient with malignancy. Khorana score predicts the venous thromboembolism in patients with malignancy. Influenced by type of malignancy, hemoglobin, platelet count, leukocyte count, and BMI. High risk = Khorana score of 2 or higher may be offered prophylaxis. Patients with pancreatic cancer and gastric cancer are particularly coagulopathic. Does the presence of a CNS lesion(s) preclude anticoagulation for a DVT/PE? All CNS lesions have a risk of hemorrhage. A CNS lesion hemorrhage is not significantly greater when anticoagulated Among high-risk cancer patients who undergo surgery, is there a role for postoperative prophylaxis with LMWH? Data show a persistent risk of VTE up to 4 weeks following abdominal/pelvic surgery.   Show notes by Emily Bryer, DO, resident in the department of internal medicine, University of Pennsylvania, Philadelphia.   References: Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update ascopubs.org/doi/pdf/10.1200/JCO.19.01461 Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer nejm.org/doi/full/10.1056/NEJMoa1814630 Apixaban to prevent venous thromboembolism in patients with cancer nejm.org/doi/full/10.1056/NEJMoa1814468   For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgehemonc Ilana Yurkiewicz on Twitter: @ilanayurkiewicz  

Associate Professor Samuel Galvagno: Thromboembolism. From CICM ASM PROGRAM 2019.  

In this episode, we review high-yield multiple choice questions related to Thromboembolism & Anticoagulation from the Basic Science section. --- Send in a voice message: https://anchor.fm/orthobullets/message

In this episode, Dr. Adolph Yates reviews the high-yield topics of Thromboembolism & Anticoagulation from the Basic Science section. Dr. Yates is a Joint Replacement Surgeon and Associate Professor of Orthopaedic Surgery at the University of Pittsburgh. --- Send in a voice message: https://anchor.fm/orthobullets/message

Commentary by Dr. Valentin Fuster

Venous thromboembolism (VTE) is one of the most preventable complications in hospitalised patients. Critically ill patients are at risk of VTE due to coexisting of multiple risk factors but, at the same time, often at risk of bleeding. Though not common, fatal pulmonary embolism (PE) continues to occur [1] – due to the alignment of failures (or ‘holes’) in each defensive layer according to the Swiss cheese model [2]. Tackling this is not easy because the pattern of the ‘holes’ in each layer of the cheese is different between patients and, to complicate the matter further, both the size and location of the ‘holes’ also change with time in each individual patient.  In brief, fatal PE occurs due to one of the three failures – failure to prevent, failure to diagnose and failure to treat (aggressively). It is well established that anticoagulants are very effective in reducing VTE. The golden rule to reduce the size of the ‘holes’ in prevention is to use a multimodal approach, with anticoagulants as a key player. The bottom line is that any anticoagulants, even at a reduced dose, is better than no anticoagulant. Judging bleeding risk to determine when anticoagulant prophylaxis can be safely initiated solely based on INR or aPTT is a last century practice. As for diagnosing PE in the critically ill, computed tomography pulmonary angiography (CTPA) is the practical gold standard. While contrast-induced-nephropathy (CIN) is real and critically ill patients are certainly at risk, the benefits of a CTPA will almost always outweigh the risk of CIN when intensivists suspect their patients may have PE (or when the pre-test probability is >10-15%)[3,4]. Immediate aggressive systemic anticoagulation is pivotal in confirmed PE. It is better to aim at a higher aPTT (80-100s) target than a lower one (e.g. 60-80s) as soon as possible to avoid clot propagation which may lead to requiring even higher risk therapies, such as thrombolysis, extracorporeal membrane oxygenation (ECMO) or surgical embolectomy. For those unfortunate few individuals who continue to deteriorate despite systemic anticoagulation, the options ‘to lyse, suck, use ECMO, or remove’ are endless; but in reality the choice is often limited by what expertise is most available at the time of crisis.    Finally, the controversial issue of using inferior vena cava filters as a primary VTE prophylaxis in patients with contraindications to anticoagulants will be discussed, including the results of our recently completed randomized controlled trial [5].    References:  [1] Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism   after major trauma: a nested cohort study. Br J Anaesth 2010;105:596-602.  [2] Reason J. Human error: models and management. BMJ 2000; 320: 768-70.  [3] Ho KM. Balancing the risks and benefits of using emergency diagnostic radiocontrast studies to diagnose life-threatening illness in critically ill patients: a decision analysis. Anaesth Intensive Care 2016;44:724-8.  [4] Ho KM, Harahsheh Y. Predicting contrast-induced nephropathy after CT pulmonary angiography in the critically ill: a retrospective cohort study. J Intensive Care 2018;6:3.  [5] Ho KM, Rao S, Honeybul S, Zellweger R, Wibrow B, Lipman J, Holley A, Kop A, Geelhoed E, Corcoran T. Detailed assessment of benefits and risks of retrievable inferior vena cava filters on patients with complicated injuries: the da Vinci multicentre randomised controlled trial study protocol. BMJ Open 2017;7:e016747. 

In this session, we will review thromboembolism in pregnancy based on the July 2018 ACOG Practice Bulletin. We will cover DVT and PE presentation, work up, and management. Delivery considerations will also be reviewed.

ATLANTA—Six months follow up of the Select-D randomized open label multicenter pilot study with 406 patients has confirmed that therapy with the direct oral anticoagulant (DOAC) rivaroxaban was a safe and effective alternative strategy to standard treatment with the low …

ATLANTA—Six months follow up of the Select-D randomized open label multicenter pilot study with 406 patients has confirmed that therapy with the direct oral anticoagulant (DOAC) rivaroxaban was a safe and effective alternative strategy to standard treatment with the low …180131 Annie Young INTERVIEW PRODUCTION MASTER

ATLANTA— In patients with a variety of cancers oral therapy with edoxaban—a direct oral anticoagulant (DOAC)—was just as effective and safe in terms of the risks of recurrent venous thromboembolism (VTE) and bleeding as injections with the low molecular weight …GARY RASKOB Mono INTERVIEW Productdion MASTER

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 23/30, 2018 issue

Commentary by Dr. Valentin Fuster

Commentary by Dr. Valentin Fuster

Commentary by Dr. Valentin Fuster

Commentary by Dr. David Wilber

What is the quality of the evidence behind extended duration venous thromboembolism (VTE) prophylaxis after discharge. Hear Dr. Feral Fleming discuss a recent review of a state database with reviewer Dr. William Cirocco.

Drs Harrington and Gibson give their annual review of the highs and lows in medicine with a focus on cardiology.

Dr Harrington interviews Dr John Brush about his exploration of cognitive psychology (behavioral economics) and how it can improve physician decision-making.

Dr Harrington interviews HEAT-PPCI principal investigator Dr Rod Stables about engaging the hospital community in research and the benefits for all concerned.

Drs. Harrington and Ohman discuss the findings and agree to disagree on the ethics of delayed consent.

Although more common in cats, aortic thromboembolism (ATE) can be seen in dogs as well. While ATE in cats is commonly seen with heart disease, the pathogenesis and presentation of ATE in dogs can be variable. In this veterinary podcast, VetGirl evaluates ATE in dogs including presentation, underlying causes, treatment options, and prognosis.

Although more common in cats, aortic thromboembolism (ATE) can be seen in dogs as well. While ATE in cats is commonly seen with heart disease, the pathogenesis and presentation of ATE in dogs can be variable. In this veterinary podcast, VetGirl evaluates ATE in dogs including presentation, underlying causes, treatment options, and prognosis.

The pathology of thromboembolism

A Pecha Kucha discussing the intensive care management of aneurysmal subarachnoid haemorrhage. This includes glycaemic control, haemoglobin targets, venous thromboembolism, fever, volume monitoring and fluid therapy. This is the 2nd of 5 PK's.

Andy Wilkinson and Eamonn Sheerin are registrars currently working in ICU in Sydney. They are relatively new to ICU and have been looking into why we do some of what we do on our daily ward rounds. This podcasts focuses on ways of remembering the important things that can be forgotten and in particular stress ulcer prophylaxis and venous thromboembolism prophylaxis. Eamonn is the Talking Heads fan and Andy has a soft spot for East 17.

The pathology of thromboembolism

More than half of hospital patients are likely to be at risk of venous thromboembolism, and measures should be taken to ensure appropriate preventative treatments (prophylaxis) are given, concludes Alexander Cohen, Kings College London, UK, lead author of the ENDORSE study, in this week's podcast.